LB Phar­ma­ceu­ti­cals rais­ing $75M for schiz­o­phre­nia drug as Karuna looks to change the field

As Karuna Ther­a­peu­tics wraps up its FDA ap­proval re­quest for what could be the first new type of schiz­o­phre­nia drug in decades, an­oth­er East Coast …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.